4//SEC Filing
ASELAGE STEVE 4
Accession 0001209191-23-019300
CIK 0001069308other
Filed
Mar 15, 8:00 PM ET
Accepted
Mar 16, 4:30 PM ET
Size
5.6 KB
Accession
0001209191-23-019300
Insider Transaction Report
Form 4
ASELAGE STEVE
Director
Transactions
- Award
Stock Option (right to buy)
2023-03-14+20,000→ 20,000 totalExercise: $1.67Exp: 2033-03-14→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]The option, which is made as part of the Issuer's 2023 annual compensation cycle, vests and becomes exercisable in full on March 14, 2024.
Documents
Issuer
Acer Therapeutics Inc.
CIK 0001069308
Entity typeother
Related Parties
1- filerCIK 0001221599
Filing Metadata
- Form type
- 4
- Filed
- Mar 15, 8:00 PM ET
- Accepted
- Mar 16, 4:30 PM ET
- Size
- 5.6 KB